GLP-1 TV · Patient story · views checked Oct 2026
The Dark Truth Behind Hims & Hers’ Super Bowl Ad
Our summary
In this video, James Li of the channel 51-49 reacts to the Hims & Hers Super Bowl ad. He says the first half of the ad criticizes America's obesity epidemic and food system, and that he initially liked it. He then says the ad turns into a pitch for weight loss drugs sold by the telehealth company, which he calls a switch that undercuts its anti-establishment tone.
One person's experience, in their words. Not medical advice.
Where semaglutide costs least today
The three cheapest partner programs for semaglutide, all in per month, checked weekly.
What else the video covers
Li explains that Hims & Hers began as a men's health company and moved into weight loss in 2023, selling compounded semaglutide, which he describes as a knockoff of Ozempic and Wegovy. He says the company brands itself as anti-Big Pharma. He gives the prices he cites as $1,300 a month for Wegovy from Novo Nordisk and $165 a month from Hims & Hers, and says the company's revenue rose by over 50% after it began offering compounded drugs. He describes how GLP-1 receptor agonists work and lists side effects he mentions, including nausea, pancreatitis, gallbladder disease, kidney problems, a boxed warning for thyroid cancer and possible bone loss, and plays a clip of a woman who reports osteoporosis after a year on Ozempic.
He says the FDA does not vet compounded medications and has warned about dosing errors and counterfeit versions. He acknowledges the argument that the FDA may favor Big Pharma, but says Hims & Hers is a Silicon Valley startup that wants to join Big Pharma, not take it on. His closing view is that another drug will not fix obesity and that food, work culture and access to healthy living need to change. He adds that he does not tell people not to take a weekly shot.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 0:42 Li says the ad opens by criticizing the food system and obesity crisis, then pivots to selling weight loss drugs from Hims & Hers.
- 2:13 He says Hims & Hers moved from men's health into weight loss in 2023 and sells compounded semaglutide, a version of Ozempic and Wegovy.
- 2:44 He cites $1,300 a month for Wegovy versus $165 a month from Hims & Hers, and says its revenue rose over 50% after it began offering these drugs.
- 4:16 He lists side effects of GLP-1 drugs, including nausea, pancreatitis, a thyroid cancer boxed warning and possible bone loss.
- 5:49 He says the FDA does not vet compounded versions and has reported hundreds of adverse events, which he thinks are likely undercounted.
- 7:55 He argues that fixing food and the way people live matters more than another drug, while saying he is not telling people to avoid a weekly shot.
Key moments
From the creator's own chapters. Tap one to play from there.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- semaglutide
- Prices mentioned
- $165 a month
- Who is speaking
- Patient
Questions this video answers
What does the Hims & Hers Super Bowl ad say about weight loss drugs?
According to the video, the ad first criticizes the obesity epidemic and a food system built to keep people sick, then presents Hims & Hers pills and vials as a solution. Li says this pivot is why he finds the ad hypocritical.
How much does compounded semaglutide from Hims & Hers cost compared with Wegovy?
Li says Wegovy from Novo Nordisk costs $1,300 a month, while Hims & Hers charges $165 a month for its compounded version.
Does the FDA review compounded semaglutide?
Li says the FDA does not vet compounded medications and has not reviewed or tested these alternatives for safety or efficacy. He says the FDA posted a warning in December about dosing errors and possible counterfeit versions, and reported hundreds of adverse events.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
Hims & Hers' Super Bowl ad sparks backlashAccording to the video, a Good Morning America segment reports on controversy around a Super Bowl ad from the telehealth company Hims & Hers.
Hims and Hers under scrutiny after weight loss ad during Super BowlAccording to this ABC News report, republished by WHAS11, a Super Bowl ad from the telehealth company Hims and Hers has set off a controversy.
‼️HIMS CANCELS WEIGHT LOSS PILL! 💥 IS THIS THE END?!According to the video, the creator of the Earn It - Save It - Invest It channel recorded this on the weekend after a fast sequence of events involving Hims & Hers.
Wegovy Pill Hits 2 MILLION Prescriptions! But Novo Has a ProblemThis episode of The Downsize News, hosted by Christopher and Lorraine Durham, covers eight GLP-1 news stories for May 11, 2026.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Is Hims legit? What its GLP-1 program costs, what reviews say, and its FDA record
Yes. Hims & Hers is a real, licensed telehealth company, and as of October 2026 its weight-loss program sells FDA-approved brand-name GLP-1s: the Wegovy pill starts at $149 a month for the medication, plus a membership of $39 for the first month and $149 a month after, so about $298 a month from month two. It scores 2.9 on Trustpilot across 9,517 reviews, and FDA sent it a warning letter in September 2025 over compounded semaglutide marketing claims.
- The best GLP-1 for weight loss, ranked by the evidence and then by the bill
By weight lost, the order is settled: tirzepatide (Zepbound) first at 20.2% in the only head-to-head, then semaglutide 7.2 mg (Wegovy HD) at 18.7%, then semaglutide 2.4 mg (Wegovy) at 13.7% to 15.6%, then the pills. By what you pay, the order nearly inverts: compounded semaglutide from $69 a month, the Wegovy tablet from $149, Wegovy pen $349, Zepbound $299 to $699 by dose. The best one is where those two lists meet for your budget and your plan.
- Is LifeMD legit for weight loss? The program fee, the drug prices, and the reviews
Yes. As of October 2026 LifeMD is a real telehealth company: affiliated licensed providers prescribe branded GLP-1s such as Wegovy and Zepbound, its pages carry a LegitScript seal, it scores 3.9 on Trustpilot from 4,270 reviews, and FDA's warning-letter database lists no letter to it. The catch is cost. The weight program is $39 for the first month and $149 a month after that. The drug is billed on top: Wegovy pen from $199, Zepbound vial from $299.
Find more like it
Side effectsCost and insuranceHow it works
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.